Core Laboratories (CLB) Lowers Q4 EPS Guidance, Q1 Guidance Misses, Cuts Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom forecasts quarterly sales below estimates amid rising custom AI chip competition
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Appleās foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Core Laboratories (CLB) PT Lowered to $39 at Cowen
December 31, 2019 6:05 AM ESTCowen analyst Marc Bianchi lowered the price target on Core Laboratories (NYSE: CLB) to $39.00 (from $42.00) while maintaining a Market Perform rating.
The analyst comments "4Q EPS pre-released below our consensus-low estimate. Initial 1Q revs/EPS guide implies a sequential improvement in what... More

